… Lung cancer is the leading cause of cancer death among men and women in North America.
In advanced non–small-cell lung cancer, … therapy for non–small-cell lung cancer. However, …

… Compelling evidence has accumulated that histologic assessment of infiltration patterns of
different host immune response components in non-small cell lung cancer specimens helps …

… The traditional distinction between small cell lung cancer and non–small cell lung cancer (…
subclassify lung carcinoma based on extremely small tumor samples, because NSCLC tumor …

… intrathoracic staging in non-small cell lung cancer (NSCLC) … presence of stage IIIA or IIIB
lung cancer. This suggests either … 44% of patients with newly diagnosed lung cancer, testing is …

… K-ras oncogene mutation as a prognostic marker in non-small cell lung cancer: a combined
… in patients with non-small cell lung cancer receiving vinorelbine-based chemotherapy. …

For patients with metastatic non–small-cell lung cancer (mNSCLC), the last decade has been
characterized by critical progress that has contributed to substantially improved survival. In …

… treatment of lung cancer accurately confirm the presence of stage III non–small-cell lung
cancer (… Stage III NSCLC represents one of the most heterogenous subgroups of lung cancer. …

… To assess the clinical significance of Ang expression in non-small cell lung cancer (NSCLC),
a total of 236 patients with pathological stage-I-IIIA disease were retrospectively reviewed. …

… We hypothesized that genes specifically expressed in non-small-cell lung carcinoma
histological classes would be associated with developmentally regulated genes and pathways. …

… Overall and lung cancer-specific 5-year survivals were 64.1% and 85.4%, respectively. …
cancer and lymph node metastasis can occur in patients with non–small cell lung cancers 1 cm …